Global Opioid Dependence Treatment Market Overview
Prophecy Market Insights has recently published its insights on “Global Opioid Dependence Treatment Market” for the forecast period of 2018-2029. The market is segmented into, By Drug Class (Buprenorphine, Naloxone, and Methadone), By Sales Channel (Retail Pharmacies, Hospitals, and Rehabilitation Centres), and By Region
Changing life science patterns and increasing utilization of narcotics in pain management is a major cause for opioid dependency, which is the major factor driving the growth of the global market. In addition, rise in the prevalence of the drug addiction among people across the globe is also boosting the target market growth. Also, increase in the dependency on pharmacological therapies for drug addiction is expected to propel the growth of the global market during the forecast period.
North America to grow at the highest CAGR during the forecast period
North America has the largest market and is expected to dominate the global market over the forecast period due to high prevalence in this region. Europe has the second largest market in terms of revenue.
The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.
In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.
The global opioid dependence treatment market report segments the market on the basis of drug class, supply channel, and region.
The report expected to answer various target market related questions and offers insights on:
- Definition, description, overview of market growth influencing factors, and forecast for the target market
- Scope for related market in the forecast period
- Analysis and outcome for the global opioid dependence treatment market by segment and region followed by countries
- Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
- Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
- Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
- Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economical factors that may influence market growth
- PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index
Competitive Analysis
Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global opioid dependence treatment market. Key players have adopted mergers & acquisitions and new product developments to strengthen their positions in the global opioid dependence treatment market. For instance,
- Reckitt Benckiser Pharmaceuticals Inc
- Mylan
- Reddy's Laboratories
- ADAPT Pharma, Inc.
- LUMITOS AG
Prophecy Market Insights offers required customization on this report according to specific business requirements.
Global Opioid Dependence Treatment Market Table of Contents
Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Drug Class
- Market Snippet, By Sales Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
Opioid Dependence Treatment Market, By Drug Class, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Buprenorphine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Naloxone
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Methadone
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Opioid Dependence Treatment Market, By Sales Channel Formulation, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Retail Pharmacies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Rehabilitation Centres
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Opioid Dependence Treatment Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Sales Channel, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Sales Channel, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Sales Channel, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Sales Channel, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Sales Channel, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles
- Reckitt Benckiser Pharmaceuticals Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Mylan
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Reddy's Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- ADAPT Pharma, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- LUMITOS AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global opioid dependence treatment market report segments the market on the basis of drug class, supply channel, and region.
the development of novel medications for opioid dependence, advancements in behavioral therapies, and the integration of digital health solutions for treatment support.
the rising incidence of opioid dependence and opioid use disorders, government initiatives to combat the opioid epidemic, and efforts to reduce the stigma associated with addiction treatment.
Regions typically considered include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The dominance of the market may depend on factors such as the prevalence of opioid dependence, healthcare infrastructure, government policies addressing substance use disorders, and cultural attitudes towards addiction treatment.
Reckitt Benckiser Pharmaceuticals Inc, Mylan, Reddy's Laboratories, ADAPT Pharma, Inc., LUMITOS AG,